［1］Siegel RL，Miller KD，Jemal A.Cancer statistics，2019［J］.CA：A Cancer Journal for Clinicians，2019，69(1)：7-34.
［2］ZHOU BS，WANG TJ，ZHANG QD，et al.The risk factors of female lung adenocarcinoma［J］.China Public Health，2000，16(6)：536-539.［周宝森，王天爵，张群弟，等.女性肺腺癌危险因素分析［J］.中国公共卫生，2000，16(6)：536-539.］
［3］Masters GA，Sarah T，Azzoli CG，et al.Systemic therapy for stage IV non-small-cell lung cancer：American Society of Clinical Oncology clinical practice guideline update［J］.J Oncol Pract，2017，33(30)：832-837.
［4］Sarli V，Giannis A.Inhibitors of mitotic kinesins：next generation antimitotics［J］.Chemmedchem，2006，1(3)：293-298.
［5］LU ZP.A study on gene screening of lung adenocarcinoma in TCGA database and prognosis of BUB1B mRNA expression［D］.Nanchang:Nanchang University，2018.［陆展鹏.基于TCGA数据库肺腺癌相关基因筛选及BUB1B mRNA表达的预后研究［D］.南昌：南昌大学，2018.］
［6］Stangel D，Erkan M，Buchholz M，et al.Kif20a inhibition reduces migration and invasion of pancreatic cancer cells［J］.Journal of Surgical Research，2015，197(1)：91-100.
［7］Khongkow P，Gomes A，Gong C，et al.Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance［J］.Oncogene，2015，35(8)：990-1002.
［8］Weijing Z，Weiling H，Yongjie S，et al.High expression of KIF20A is associated with poor overall survival and tumor progression in early-stage cervical squamous cell carcinoma［J］.PLoS One，2016，11(12)：e0167449.
［9］Shi C，Huang D，Lu N，et al.Aberrantly activated Gli2-KIF20A axis is crucial for growth of hepatocellular carcinoma and predicts poor prognosis［J］.Oncotarget，2016，7(18)：26206-26219.
［10］Gao J，Aksoy BA，Dogrusoz U，et al.Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal［J］.Science Signaling，2013，6(269)：pl1.
［11］ZHU JX.The expression of RASSF6 in advanced lung adenocarcinoma and its clinical significance［D］.Fuzhou:Fujian Medical University，2017.［朱金秀.RASSF6在晚期肺腺癌中的表达及临床意义［D］.福州：福建医科大学，2017.］
［12］Meng D，Chen Y，Yun D，et al.High expression of N-myc(and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma［J］.Oncotarget，2015，6(7)：4901-4919.
［13］Taniuchi K，Nakagawa H，Nakamura T，et al.Down-regulation of RAB6KIFL/KIF20A，a kinesin involved with membrane trafficking of discs large homologue 5，can attenuate growth of pancreatic cancer cell［J］.Cancer Research，2005，65(1)：105-112.
［14］Lu Y，Liu P，Wen W，et al.Cross-species comparison of orthologous gene expression in human bladder cancer and carcinogen-induced rodent models［J］.American Journal of Translational Research，2010，3(1)：8-27.
［15］Liu SL，Lin HX，Qiu F，et al.Overexpression of Kinesin family member 20A correlates with disease progression and poor prognosis in human nasopharyngeal cancer：A retrospective analysis of 105 patients［J］.PLoS One，2017，12(1)：e0169280.
［16］Wang M.The expression and functional mechanism study of KIF20A in gliomas［D］.Jinan:Shandong University，2018.
［17］GUO YT，YU C，SUN CY.Expression of KIF20A in hepatocellular carcinoma cells and tissues and its clinical significance［J］.Journal of Guizhou Medical University，2017，42(02)：142-146.［郭云韬，喻超，孙诚谊.KIF20A基因在肝癌细胞及组织中的表达及临床意义［J］.贵州医科大学，2017，42(02)：142-146.］
［18］SHENG Y，ZHANG SX，YAN Q，et al.Relationship between expression of KIF20A and prognosis in gastric cancer［J］.Acta Universitatis Medicinalis Anhui，2019，54(01)：116-120.［盛燚，张尚鑫，闫强，等.KIF20A在胃癌中的表达与预后的关系［J］.安徽医科大学学报，2019，54(01)：116-120.］